We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Universal Display (OLED) Q2 Earnings & Revenues Top Estimates
Read MoreHide Full Article
Universal Display Corporation (OLED - Free Report) delivered second-quarter 2019 adjusted earnings of 92 cents per share surpassing the Zacks Consensus Estimate of 46 cents.
Revenues increased 110.7% to $118.2 million and outpaced the Zacks Consensus Estimate of $77 million.
Revenues in the reported quarter include roughly $15 million to $20 million of orders from customers located in China to mitigate the impact from U.S. and China trade-related issues.
The company adopted a new Accounting Standards Codification (ASC) 606 using full retrospective method from the first quarter of 2018.
Universal Display’s stock has returned 123.3% on a year-to-date basis, significantly outperforming the industry's growth of 22.7%.
Segment Details
Material sales (64.6% of total revenues) increased 107.3% from the year-ago quarter to $76.3 million. Green emitters sales (including yellow-green emitters) were $60.2 million, up 132.4% year over year. Red emitter sales were $16 million, up from $10.9 million reported in the year-ago quarter.
Royalty and license fees (32.9% of total revenues) increased 150.9% year over year to $38.9 million. Adesis revenues came in at $2.9 million during the reported quarter compared with $3.8 million reported in the year-ago quarter.
Contract research services represented the remaining 2.5% of total revenues, declining 23.5% year over year.
Operating Details
Gross margin during the quarter under review came in at 79.6% compared with 79.3% reported in the year-ago quarter. Material gross margin contracted to 71% compared with 75% reported in the year-ago quarter.
Operating expense during the reported quarter came in at $45.4 million compared with $33.6 million reported in the year-ago quarter.
Operating margin came in at 41.2% compared with 19.4% reported in the year-ago quarter.
Balance Sheet
As on Jun 30, 2019, Universal Display had cash and cash equivalents (including short-term investments) of $552.7 million compared with $526.6 million at the end of previous quarter.
The company generated $83.9 million as cash from operating activities during the six months ended Jun 30, 2019.
The company recently approved a quarterly cash dividend payment of 10 cents per share to be paid on Sep 30, 2019 to shareholders as on Sep 16, 2019.
Guidance
Universal Display updated guidance for fiscal 2019. The company now anticipates revenues between $370 million and $390 million, under ASC 606 (previously $345 million and $365 million). Under ASC 605, the company expects revenues to be in the range of $425 million to $435 million (previously $405 million to $425 million). The Zacks Consensus Estimate for revenues is pegged at $357.9 million.
Zacks Rank & Stocks to Consider
Currently, Universal Display has a Zacks Rank #3 (Hold).
Rosetta, Alteryx and Nikon have a long-term earnings growth rate of 12.5%, 13.7% and 1%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Universal Display (OLED) Q2 Earnings & Revenues Top Estimates
Universal Display Corporation (OLED - Free Report) delivered second-quarter 2019 adjusted earnings of 92 cents per share surpassing the Zacks Consensus Estimate of 46 cents.
Revenues increased 110.7% to $118.2 million and outpaced the Zacks Consensus Estimate of $77 million.
Revenues in the reported quarter include roughly $15 million to $20 million of orders from customers located in China to mitigate the impact from U.S. and China trade-related issues.
The company adopted a new Accounting Standards Codification (ASC) 606 using full retrospective method from the first quarter of 2018.
Universal Display’s stock has returned 123.3% on a year-to-date basis, significantly outperforming the industry's growth of 22.7%.
Segment Details
Material sales (64.6% of total revenues) increased 107.3% from the year-ago quarter to $76.3 million. Green emitters sales (including yellow-green emitters) were $60.2 million, up 132.4% year over year. Red emitter sales were $16 million, up from $10.9 million reported in the year-ago quarter.
Royalty and license fees (32.9% of total revenues) increased 150.9% year over year to $38.9 million. Adesis revenues came in at $2.9 million during the reported quarter compared with $3.8 million reported in the year-ago quarter.
Contract research services represented the remaining 2.5% of total revenues, declining 23.5% year over year.
Operating Details
Gross margin during the quarter under review came in at 79.6% compared with 79.3% reported in the year-ago quarter. Material gross margin contracted to 71% compared with 75% reported in the year-ago quarter.
Operating expense during the reported quarter came in at $45.4 million compared with $33.6 million reported in the year-ago quarter.
Operating margin came in at 41.2% compared with 19.4% reported in the year-ago quarter.
Balance Sheet
As on Jun 30, 2019, Universal Display had cash and cash equivalents (including short-term investments) of $552.7 million compared with $526.6 million at the end of previous quarter.
The company generated $83.9 million as cash from operating activities during the six months ended Jun 30, 2019.
The company recently approved a quarterly cash dividend payment of 10 cents per share to be paid on Sep 30, 2019 to shareholders as on Sep 16, 2019.
Guidance
Universal Display updated guidance for fiscal 2019. The company now anticipates revenues between $370 million and $390 million, under ASC 606 (previously $345 million and $365 million). Under ASC 605, the company expects revenues to be in the range of $425 million to $435 million (previously $405 million to $425 million). The Zacks Consensus Estimate for revenues is pegged at $357.9 million.
Zacks Rank & Stocks to Consider
Currently, Universal Display has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader technology sector are Rosetta Stone , Alteryx, Inc. and Nikon Corp. (NINOY - Free Report) , each flaunting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Rosetta, Alteryx and Nikon have a long-term earnings growth rate of 12.5%, 13.7% and 1%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>